Open AccessLimitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
Author(s) -
Sonya Naryshkin,
R. Marshall Austin
Publication year - 2012
Publication title -
drug, healthcare and patient safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 24
ISSN - 1179-1365
DOI - 10.2147/dhps.s37273
Subject(s) - human papillomavirus , cervical cancer , medicine , cervical cancer screening , gynecology , oncology , risk analysis (engineering) , cancer
To increase awareness of the limitations of high-risk human papillomavirus (hrHPV) laboratory-developed testing (LDT) widely used in US cervical cancer screening.